DelveInsight’s “Pertussis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pertussis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pertussis Market Forecast
Some of the key facts of the Pertussis Market Report: https://www.delveinsight.com/sample-request/pertussis-market?utm_source=pressrelease&utm_medium=promotion&utm_campaign=akpr
- The Pertussis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- The CDC (2020) generally advises five doses of the DTaP vaccine at 2, 4, and 6 months, at 15–18 months, and at 4-6 years. It also suggests the Tdap vaccine for children aged 7–10 who have not had their full dosage of the pertussis vaccine
- According to WHO's Global Health Observatory (2021), 94% of 1-year-olds in the US had received their diphtheria-tetanus toxoid, tetanus toxoid, and pertussis (DTP3) vaccinations in 2018 and 2019, and 93% in 2020
- In 2021, there were 34,649,297 people who had received their entire 7MM dose of the pertussis vaccination
- Germany had the most vaccines out of the EU5 states, followed by France (2,619,428) and Italy (2,277,856). The UK had the fewest vaccines (2,643,017) in 2021, in comparison
- Key Pertussis Companies: ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven, VPM, and others
- Key Pertussis Therapies: BPZE1, BK1310/MT-2355, SIIPL Tdap, and others
- The Pertussis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pertussis pipeline products will significantly revolutionize the Pertussis market dynamics.
Pertussis Overview
Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is characterized by severe coughing fits, often with a "whooping" sound when the person breathes in after coughing. Pertussis can affect people of all ages, but it is particularly severe in infants and young children who have not been fully vaccinated.
Get a Free sample for the Pertussis Market Report
Pertussis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pertussis Epidemiology Segmentation:
The Pertussis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Pertussis
- Prevalent Cases of Pertussis by severity
- Gender-specific Prevalence of Pertussis
- Diagnosed Cases of Episodic and Chronic Pertussis
Download the report to understand which factors are driving Pertussis epidemiology trends @ Pertussis Epidemiology Forecast
Pertussis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pertussis market or expected to get launched during the study period. The analysis covers Pertussis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pertussis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Pertussis Therapies and Key Companies
- BPZE1: ILiAD Biotechnologies
- BK1310/MT-2355: Mitsubishi Tanabe Pharma Corporation
- SIIPL Tdap: Serum Institute/Bilthoven/VPM
Discover more about therapies set to grab major Pertussis market share @ Pertussis Treatment Market
Pertussis Market Drivers
- Increase in the recommendation of vaccination programs in pregnant women
- Increasing Awareness Programs
- Increasing population of pertussis
Pertussis Market Barriers
- Acellular vaccines less effective in the current market
- Lack of patient awareness
- Barriers to developing a new whole-cell version of pertussis vaccine
- Different vaccination policies amongst various countries
Scope of the Pertussis Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Pertussis Companies: ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven, VPM, and others
- Key Pertussis Therapies: BPZE1, BK1310/MT-2355, SIIPL Tdap, and others
- Pertussis Therapeutic Assessment: Pertussis current marketed and Pertussis emerging therapies
- Pertussis Market Dynamics: Pertussis market drivers and Pertussis market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Pertussis Unmet Needs, KOL’s views, Analyst’s views, Pertussis Market Access and Reimbursement
To know more about Pertussis companies working in the treatment market, visit @ Pertussis Clinical Trials and Therapeutic Assessment
Table of Contents
- Pertussis Market Report Introduction
- Executive Summary for Pertussis
- SWOT analysis of Pertussis
- Pertussis Patient Share (%) Overview at a Glance
- Pertussis Market Overview at a Glance
- Pertussis Disease Background and Overview
- Pertussis Epidemiology and Patient Population
- Country-Specific Patient Population of Pertussis
- Pertussis Current Treatment and Medical Practices
- Pertussis Unmet Needs
- Pertussis Emerging Therapies
- Pertussis Market Outlook
- Country-Wise Pertussis Market Analysis (2019–2032)
- Pertussis Market Access and Reimbursement of Therapies
- Pertussis Market Drivers
- Pertussis Market Barriers
- Pertussis Appendix
- Pertussis Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Related Reports:
Pertussis Pipeline https://www.delveinsight.com/report-store/pertussis-pipeline-insight?utm_source=pressrelease&utm_medium=promotion&utm_campaign=akpr
"Pertussis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pertussis market. A detailed picture of the Pertussis pipeline landscape is provided, which includes the disease overview and Pertussis treatment guidelines.
Pertussis Epidemiology https://www.delveinsight.com/report-store/pertussis-epidemiology-forecast?utm_source=pressrelease&utm_medium=promotion&utm_campaign=akpr
DelveInsight's 'Pertussis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pertussis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight’s ‘Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2030’ report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight’s “IgA Nephropathy Market Insights, Epidemiology and Market Forecast – 2032” report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: abhishek@delveinsight.com
City: Albany
State: New York
Country: United States
French
Dutch